Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Finasteride may help some women with hair loss, but better options exist.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Hair loss patients may have different polyamine levels in various scalp areas.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

High testosterone increases heart disease risk in women with PCOS.

Testosterone significantly affects urination differences between male and female mice.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Hair loss treatments work better with lifestyle changes.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.